SEC Form 4 · accession 0001651844-16-000024
NYMOX PHARMACEUTICAL CORP · NYMX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James George Robinson
Director
Period of report
Aug 1, 2016
Accepted (ET)
Aug 5, 2016 · 5:34 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001018735
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCK | Aug 1, 2016 | P | 2,500 | $3.60 | A | 2,902,550 | D | |
| COMMON STOCK | Aug 2, 2016 | P | 2,500 | $3.34 | A | 2,905,050 | D | |
| COMMON STOCK | Aug 4, 2016 | P | 1,000 | $3.29 | A | 2,906,050 | D | |
| COMMON STOCK | Aug 4, 2016 | P | 1,000 | $3.21 | A | 2,907,050 | D | |
| COMMON STOCK | holding | — | — | — | 45,050 | I | TRUST | |
| COMMON STOCK | holding | — | — | — | 45,050 | I | TRUST | |
| COMMON STOCK | holding | — | — | — | 45,050 | I | TRUST | |
| COMMON STOCK | holding | — | — | — | 45,050 | I | TRUST |
Table II — derivative securities
No Table II lines on this filing.